Kornitzer Capital Management’s OptimizeRx OPRX Stock Holding History

Kornitzer Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-225,489	Closed	-$3.22M	–	493
2023 Q2	$3.22M	Sell	225,489 -127,505	-36%	-$1.82M	0.06%	286
2023 Q1	$5.16M	Buy	352,994 +53,055	+18%	+$888K	0.1%	250
2022 Q4	$5.04M	Buy	299,939 +69,575	+30%	+$1.2M	0.1%	253
2022 Q3	$3.41M	Hold	230,364	–	–	0.07%	270
2022 Q2	$6.31M	Buy	+230,364	New	+$6.83M	0.13%	234

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Kornitzer Capital Management's OPRX Position: Q3 2023 in Review

Kornitzer Capital Management sold out of OptimizeRx (OPRX) in Q3 2023, closing a stake of 225,489 shares — an estimated $3.22M sold.

Kornitzer Capital Management first reported a position in OPRX in Q2 2022 and held it in 5 quarters. The position peaked at $6.31M in Q2 2022. 94 funds tracked by Wall St. Rank hold OPRX as of Q3 2023.

Kornitzer Capital Management reported no remaining OptimizeRx position as of Q3 2023 after selling out during the quarter.
Kornitzer Capital Management sold 225,489 OptimizeRx shares in Q3 2023, an estimated $3.22M.
Kornitzer Capital Management first reported a position in OptimizeRx in Q2 2022 and held it in 5 quarters.
Kornitzer Capital Management's OptimizeRx position peaked at $6.31M in Q2 2022.
94 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2023.

Based on Kornitzer Capital Management's 13F filing for Q3 2023, filed 31 Oct 2023.